L-arginine as a novel target for clinical intervention in inflammatory bowel disease
Arginase-1 (Arg1) and the inducible nitric oxide synthase 2 (NOS2) compete for the common substrate L-arginine, semi-essential amino acid, and central intestinal metabolite. Both enzymes exhibit various, sometimes opposing effects on immune responses, tissue regeneration, or microbial growth and rep...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Open Exploration Publishing Inc.
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/795628a54bfe46eca020af5f2c59efd8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|